Affiliation:
1. Facultad de Ciencias Biológicas, Universidad Central del Ecuador, Quito, Ecuador.
2. Hospital Quito Sur del Instituto Ecuatoriano de Seguridad Social, Quito, Ecuador.
Abstract
COVID-19 exhibits a wide range of phenotypic manifestations, from asymptomatic to severe phenotypes with fatal complications. The exis-tence of risk factors cannot entirely explain the variance in the phenotypic vari-ability of COVID-19. Genome-wide association analyses have identified target human genes related to virus transmission and the clinical phenotype observed in COVID-19 patients. Genetic variants on the OAS1 gene have been associ-ated with innate immune processes (entry phase and viral replication in host cells). The A or G alleles of rs10774671 in OAS1 encode isoforms with different antiviral activities. One hundred COVID-19 patients were genotyped for the rs10774671 using RFLP-PCR (severe form, n = 43; asymptomatic-mild, n = 57). The susceptibility of the two groups to the severe phenotype of COVID-19 was compared. The allele frequency for A was 0.8. The genotypic frequencies for AA and GG homozygotes were 0.62 and 0.02, respectively. A Hardy-Weinberg equilibrium deviation was found in both groups. No statistically significant as-sociations were found in genetic models adjusted for sex (for the additive model OR = 1.18, 95% CI = (0.53-2.61), p = 0.69). A relatively recent mix of different ethnic groups and sample size may influence these findings.
Reference31 articles.
1. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol 2020; 215: 108427. https://doi:10.1016/j.clim.2020.108427.
2. WHO. https://covid19.who.int. 2023. The WHO Coronavirus (COVID-19) Dashboard.
3. World Health Organization. https://www.who.int/publications/i/item/clinical-care-of-severe-acute-%0Arespiratory-infections-tool-kit. 2023. Clinical Care for Severe Acute Respiratory Infection.
4. Shahid Z, Kalayanamitra R, McClafferty B, Kepko D, Ramgobin D, Patel R, Aggarwal CS, Vunnam R, Sahu N, Bhatt D, Jones K, Golamari R, Jain R. COVID-19 and older adults: what we know. J Am Geriatr Soc 2020; 68(5): 926–929. https://doi:10.1111/jgs.16472
5. Godri Pollitt KJ, Peccia J, Ko AI, Kaminski N, Dela Cruz CS, Nebert DW, Reichardt JKV, Thompson DC, Vasiliou V. COVID-19 vulnerability: the potential impact of genetic susceptibility and airborne transmission. Hum Genomics 2020; 14(1): 17. https://doi:10.1186/s40246-020-00267-3.